Coastal Infusion Administers Yervoy™
| J-Code | J9228 |
|---|---|
| Manufacturer | Bristol-Myers Squibb |
| First Approved | 03/25/2011 |
Coastal Infusion can administer your Yervoy prescription at any of our south Florida locations.
Yervoy (ipilimumab) is a cancer medicine used to treat advanced melanoma. It can also be used to treat advanced renal cell carcinoma, non-small cell lung cancer (NSCLC), malignant pleural mesothelioma (a cancer of the lining of the lungs), colon or rectum cancer, and advanced squamous esophageal cancer.
Yervoy is usually used in combination with nivolumab (another cancer medicine), but it can also be used on its own for melanoma. The active substance in Yervoy, ipilimumab, is a monoclonal antibody that increases the number and the activity of a type of white blood cells called T cells which form part of the immune system, and which can kill cancer cells.
What It Treats
- Advanced Melanoma and cutaneous squamous cell carcinoma (cSCC)
- Advanced Renal Cell carcinoma
- Non-small cell lung cancer (NSCLC)
- Malignant pleural mesothelioma
- Colon, rectum, and esophageal cancers
- Other cancers
Prescribed By
Yervoy is most often prescribed by Oncologists, Dermatologists, Urologists, Pulmonologists, Gastroenterologists, and others.
How it’s Administered
Yervoy is administered by intravenous infusion. Yervoy infusions take about 90 minutes.
Frequency
Yervoy is generally administered every two, three, or four weeks.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies